"Outre l'industrie du générique qui grignote les brevets existants, le secteur souffre aujourd'hui d'une grave crise de productivité de sa recherche : les nouveaux produits manquent qui pourraient remplacer les plus anciens."
 "Last year, the U.S. FDA approved only 21 new drugs, marking a steady decline since a peak of 53 in 1996. Many of the world's largest drug companies failed to win U.S. approval for a single new drug in 2003."
 "Many observers believe the introduction of new technology in the 1990s helps to explain today's drought of new drugs, which take years between discovery and approval. "Ten years later, we're seeing the effects. The output has decreased tremendously."  "The underlying challenge [...] is to address the innovation deficit. But how? Flashy new drug-discovery technology has lost its shine, having consumed huge sums of money during the 1990s with little to show for it. Yet something new is undoubtedly needed."

«	page 2/3	»
	1